Market evolution: Rubber hygienic pharmaceutical articles (CN 4014) — 2015–2025

Introduction

This report analyses the EU's external trade in goods classified under customs code 4014, which encompasses hygienic or pharmaceutical articles of vulcanised rubber, such as teats, excluding apparel and gloves. The analysis covers the period from 2015 to 2025, based on complete annual data. Over this decade, the market experienced profound structural changes characterized by robust export growth, a reorientation of trade partnerships, and a dramatic transformation in the EU's productive base. The overall trade deficit narrowed significantly, driven by a surge in export values outpacing import growth. Key dynamics include a shift towards higher-value exports, increased geographic concentration of trade, and a strategic pivot in EU production from volume to value.

1. A Decade of Strong Export-Led Growth and Price Evolution

The EU's trade in rubber hygienic articles showed distinct growth patterns between exports and imports, alongside a significant rise in average unit prices, particularly for exports.

EU exports outpaced imports in value growth, narrowing the trade deficit.

Over the period, the value of EU exports more than doubled, increasing from €93.3 million in 2015 to €207.6 million in 2025 (+122.4%). Import values also grew substantially, from €138.2 million to €219.3 million (+58.7%). Consequently, the EU's trade deficit in this sector shrank from -€44.9 million to -€11.7 million, a 73.9% improvement. This indicates a strengthening of the EU's competitive position in global markets for these goods.

Export volume grew modestly, implying a dominant role for rising prices in the value surge.

While export values soared, the quantity shipped (net mass) grew by a more modest 28.9%, from 4,541 tonnes to 5,853 tonnes. This points to a substantial increase in the average export price, which rose by 72.6% from €20,550 per tonne to €35,466 per tonne. Import prices also increased, but less dramatically, rising by 32.0% from €15,866 to €20,947 per tonne. This price dynamic suggests a potential shift in the EU's export basket towards higher-value, specialised products within this category.

The product sub-segment reveals divergent import and export price trends.

The category CN 4014 bundles two main products: sheath contraceptives (401410) and other hygienic/pharmaceutical articles (401490). Their trade dynamics differ starkly. For imports, the value of contraceptive imports (401410) grew rapidly, from €67.4 million to €160.8 million, driven by a massive 109% price hike from €16,878 to €35,362 per tonne. In contrast, the value of imports of other articles (401490) actually declined slightly, from €70.8 million to €58.5 million, with prices falling from €15,006 to €9,874 per tonne. For exports, the value of both sub-categories grew healthily, but prices for other articles (401490) rose particularly sharply by 78.2%, from €19,778 to €35,239 per tonne.

Source: Product Segment Breakdown

2. Shifting Trade Partnerships and Increased Market Concentration

The geographic landscape of EU trade for CN 4014 underwent significant realignment, marked by the rise of Asian exporters, a redefinition of the EU's key export destinations, and increased concentration on both sides of the trade flow.

Thailand and China became the dominant sources of EU imports, while traditional partners declined.

In 2015, imports were led by Germany's neighbouring and Western partners. By 2025, the picture was dominated by Asian producers. Thailand saw the most dramatic growth, with import values soaring by 244.0% to become the top partner at €87.9 million. China also grew significantly (+128.9% to €75.1 million). Meanwhile, imports from Switzerland and the United Kingdom collapsed by 80.5% and 58.7% respectively, indicating a major sourcing shift, likely driven by cost considerations and production relocations.

The EU's export market diversified geographically, with strong growth in Asia and North America.

The United States and China emerged as the EU's premier export markets. Exports to the US surged by 280.9% to €38.9 million, making it the top destination. Exports to China grew even faster, by 424.8% to €38.7 million. Other key growth markets included Switzerland (+188.5%) and India (+354.0%). This pattern suggests a successful penetration of high-growth or high-value markets. The UK remained a stable market in value terms (+1.2%), though its relative share likely decreased.

Trade became more concentrated on both the import and export side.

The Herfindahl-Hirschman Index (HHI) for import concentration by partner nearly doubled, from 1,571 to 2,924. This move towards a more concentrated (less diverse) import base is driven by the growing dominance of Thailand and China. Export concentration also increased, with the HHI rising from 530 to 1,018, reflecting the growing importance of the US and China as anchor markets.

3. A Transformation in Production and a Leap in Strategic Autonomy

The EU's domestic production profile for this sector underwent a fundamental transformation, pivoting from high-volume to high-value output. This shift, combined with vigorous export growth, drastically reduced the sector's historical vulnerability to import reliance.

EU production volume plummeted while value skyrocketed, indicating a strategic shift to higher-value-added segments.

Reported production quantity for the sector (in kg) fell dramatically by 72.6%, from 1.17 billion kg in 2015 to 320 million kg in 2025. Concurrently, production value exploded by 1,510.6%, soaring from €96.6 million to €1.556 billion. This divergence is extreme and suggests a massive redefinition of the production base—likely a move away from high-volume, lower-margin items (like standard condoms) towards higher-value, specialty pharmaceutical or medical rubber articles. It may also reflect reporting changes or increased specialisation by fewer, more advanced producers.

Source: Market Structure

Net import reliance collapsed, reflecting a substantial improvement in the EU's strategic autonomy.

The EU's net import reliance (imports minus exports as a share of apparent consumption) shifted from 22.7% in 2015 to a negligible 0.8% in 2025, a reduction of 96.3%. In some years, the EU even became a net exporter (with a negative reliance). This collapse in vulnerability was driven by the strong performance of exports and the shift in production, meaning the EU's sector is now far less dependent on the rest of the world to meet its domestic demand.

The EU maintains clear specialisation advantages, led by France.

Revealed Symmetric Comparative Advantage (RSCA) data for 2025 shows that France holds a strong specialisation in this product group (RSCA = 0.564), followed by Denmark (0.447) and Latvia (0.393). France alone accounts for 28% of EU production value and nearly 8% of total trade, underscoring its central role. In contrast, countries like Portugal and Austria show significant disadvantage. This confirms that within the EU, production and competitive capacity are highly concentrated in a few member states.

Conclusion

The EU trade market for rubber hygienic articles (CN 4014) over 2015–2025 is a story of successful reorientation and value capture. Faced with intense competition in high-volume segments, the EU demonstrably pivoted its strategy. Exports became the engine of growth, driven by rising prices and penetration into high-value markets like the US, China, and Switzerland. This was enabled by a radical transformation of the domestic production base, which moved away from sheer volume towards dramatically higher value, effectively erasing the sector's net import reliance.

However, this success is coupled with increased market concentration risks: imports now depend more heavily on Thailand and China, and exports are more focused on the US and China. The strong specialisation of a few member states, particularly France, also highlights internal dependencies. Moving forward, the sector's stability will depend on navigating the geopolitical and economic dynamics with its key partners while continuing to innovate and command premium prices in the global marketplace.